New AA (Allergan Aesthetics) Signature™ multimodal treatment approach to be presented at AMWC Dubai following successful launch in 25 countries so far this year. Experts to explore the paradigm shift in medical aesthetics and decode […]
Tag: AbbVie
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
Partnership marks AbbVie’s entrance into the obesity field Agreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie’s global infrastructure for developing and commercializing therapies for patients in […]
Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day
Last Year, BOTOX® Cosmetic Day Set the Record for the Most BOTOX® Cosmetic Gift Cards Sold in a Single Day1 This Year, the Excitement Continues with New Offers to Refer a Friend Plus the Best-Selling Buy-One-Get-One […]
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
The Only Product of Its Kind Approved for Use in Four Aesthetic Indications: Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines, Frown Lines, Crow’s Feet Lines, and Now Platysma Bands in Adults1-5 […]
Allergan Aesthetics and Girls Inc. Celebrate Six Years and Challenge You to Take the Pledge to Support Mentorship in STEM
— Live panel discussion at the Girls Inc. Be Bold LeadHERS Summit at Houston Community College with expert women healthcare providers IRVINE, Calif., Oct. 4, 2024 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company, announces the […]
